- Fructose‐1,6‐bisphosphate induces generation of reactive oxygen species and activation of p53‐dependent cell death in human endometrial cancer cells
Bruna Pasqualotto Costa et al, 2021, Journal of Applied Toxicology CrossRef - Fructose-1,6-bisphosphate decreases IL-8 levels and increases the activity of pro-apoptotic proteins in HepG2 cells
Gabriele Catyana Krause et al, 2017, Biomedicine & Pharmacotherapy CrossRef - CPBMF65, a synthetic human uridine phosphorylase-1 inhibitor, reduces HepG2 cell proliferation through cell cycle arrest and senescence
Elisa Feller Gonçalves da Silva et al, 2020, Investigational New Drugs CrossRef - The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
Dimakatso Alice Senthebane et al, 2017, International Journal of Molecular Sciences CrossRef - Targeting FBPase is an emerging novel approach for cancer therapy
Gao-Min Liu et al, 2018, Cancer Cell International CrossRef - Fructose-1,6-Bisphosphate Prevents Bleomycin-Induced Pulmonary Fibrosis in Mice and Inhibits the Proliferation of Lung Fibroblasts
Renan Trevisan Jost et al, 2018, Inflammation CrossRef - Autophagy: Dual Response in the Development of Hepatocellular Carcinoma
Hamza O. Yazdani et al, 2019, Cells CrossRef - Fructose-1,6-bisphosphate prevents pulmonary fibrosis by regulating extracellular matrix deposition and inducing phenotype reversal of lung myofibroblasts
Henrique Bregolin Dias et al, 2019, PLOS ONE CrossRef